Research

Hormonal

Incretin polyagonists (dual and triple agonists) produce weight loss and metabolic improvements comparable to, or approaching, those of bariatric surgery, serving as a potent non-surgical alternative.

If you have obesity and want significant weight loss without surgery, incretin polyagonists (like tirzepatide or retatrutide) are now a viable, highly effective medical option. They work by mimicking gut hormones to reduce appetite and improve metabolism. While they require weekly injections (or soon, oral pills), they can achieve weight loss results similar to bariatric surgery. Expect some initial stomach upset, which usually fades as your body adjusts. Consult a doctor to see if you are a candidate.

GoodSupportsHIGH confidence
Recent clinical trials demonstrate that dual and triple agonists can produce weight reductions comparable to, or in some cases approaching, those seen with bariatric surgery, while simultaneously improving glycemic control, lipid profiles, liver fat, and cardiovascular risk factors.
Rohit Jacob Manoj et al. · World Journal of Gastrointestinal Pathophysiology · 2026

Why this rating

Based on multiple phase 3 RCTs (SURPASS, SURMOUNT) and meta-analyses cited.

Source

Incretin polyagonists as an alternative to bariatric surgery to manage obesity

Rohit Jacob Manoj et al. · World Journal of Gastrointestinal Pathophysiology · 2026

DOI 10.4291/wjgp.v17.i1.118132

narrative_review
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →